Antisense Therapeutics Limited Analysis
Antisense Therapeutics Limited is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Antisense Therapeutics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Antisense Therapeutics Limited is worth, separate from its market price. There are two main types of Antisense Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Antisense Therapeutics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Antisense Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Antisense |
Antisense Pink Sheet Analysis Notes
About 19.0% of the company shares are held by company insiders. The book value of Antisense Therapeutics was presently reported as 0.03. The company recorded a loss per share of 0.01. Antisense Therapeutics had not issued any dividends in recent years. The entity had 50:49 split on the 10th of April 2018. Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia. Antisense Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Antisense Therapeutics Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Antisense Therapeutics Limited please contact the company at 61 3 9827 8999 or go to https://www.antisense.com.au.Antisense Therapeutics Investment Alerts
| Antisense Therapeutics is not yet fully synchronised with the market data | |
| Antisense Therapeutics has some characteristics of a very speculative penny stock | |
| Antisense Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.78 M. Net Loss for the year was (5.81 M) with profit before overhead, payroll, taxes, and interest of 1.71 M. | |
| Antisense Therapeutics Limited has accumulated about 19.23 M in cash with (7.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 19.0% of the company shares are held by company insiders |
Antisense Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 41.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Antisense Therapeutics's market, we take the total number of its shares issued and multiply it by Antisense Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Antisense Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Antisense Pink Sheet
If you are still planning to invest in Antisense Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Antisense Therapeutics' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |